M&A Watch: Comprehensive Consumer Healthcare M&A Intelligence Service

Why buy this report?

"The M&A Watch is part one of our new M&A strategic intelligence service purpose-built for Consumer Healthcare leaders navigating this evolving landscape.

Why this matters now:

The sector has seen 150+ significant transactions since 2020, with notable divergence in how Private Equity sponsors versus strategic acquirers approach valuations. Deal multiples vary substantially by category (vitamins, supplements, OTC, wellness) and geography, yet comprehensive, sector-specific benchmarking remains elusive.

Our differentiated approach:

Unlike generic M&A databases, this Register is compiled by advisors who execute transactions in your sector. Our team has recently supported:

CapVest/Stada: Consumer Healthcare workstream for majority stake acquisition

Dr Reddy's/Haleon: Buy-side due diligence on Nicotinell acquisition, including post-merger integration

Cooper Consumer Health/Viatris: Sell-side strategic consulting on OTC portfolio divestment

Zentiva/Sanofi: Commercial due diligence on OTC asset acquisition

Strategic applications for your organisation:

Portfolio Strategy: Benchmark your business units against comparable transactions to inform build vs. buy vs. divest decisions

Capital Allocation: Understand valuation ranges and premium drivers to optimise investment timing and resource deployment

Competitive Intelligence: Track consolidation patterns and buyer behaviour to anticipate market shifts

Transaction Readiness: Arm your corporate development team with credible valuation expectations and comparable precedents

What's included:

The Register provides 150+ transaction records (2020-YTD'25) with complete financial metrics, accompanied by strategic analysis of buyer behaviour patterns, valuation segmentation by category and geography, and deal rationale context. This is intelligence designed to inform board-level decisions, not raw data.

"

Nicholas Hall